Huang, YunjiePaul, GraceLee, JesunYarlagadda, SunithaMcCoy, KarenNaren, Anjaparavanda P.2024-09-232024-09-232021Huang Y, Paul G, Lee J, Yarlagadda S, McCoy K, Naren AP. Elexacaftor/Tezacaftor/Ivacaftor Improved Clinical Outcomes in a Patient with N1303K-CFTR Based on In Vitro Experimental Evidence. Am J Respir Crit Care Med. 2021;204(10):1231-1235. doi:10.1164/rccm.202101-0090LEhttps://hdl.handle.net/1805/43516en-USPublisher PolicyAminophenolsBenzodioxolesCystic fibrosis transmembrane conductance regulatorGene expression regulationPyrazolesPyrrolidinesQuinolonesElexacaftor/Tezacaftor/Ivacaftor Improved Clinical Outcomes in a Patient with N1303K-CFTR Based on In Vitro Experimental EvidenceArticle